About Covira

Covira Surgical engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria. It is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira’s platform technology generated a lead asset (CS-0003) that modulates bacterialvirulence and restores microbial communities to prevent post-surgical infection. Covira’s approach is transformative to the field and the world is taking notice...in the 4th quarter of last year, Business Worldwide Magazine named Covira Among the 2021 - Top 20 Most Innovative Companies to Watch.

Founded
2018
Employees
1 to 10
Total funding
$10.1M

Leadership

The top of Covira's org chart, with how many people report into each leader.

SMPhoto of Sharon Ayd, Ph.D., MBA

Sharon Ayd, Ph.D., MBA

Chief (Fractional) Regulatory Advisor

BFPhoto of Bekah Farmakis

Bekah Farmakis

Executive Assistant

Jobs at Covira

No open positions right now. Explore more companies on TheJobsMap.